Confidential HSV consults • Boca Raton & Jupiter

A Precision Approach to Herpes Outbreaks

Doctors Studio offers a personalized oligonucleotide infusion designed to inhibit HSV replication—for people who want options beyond “just manage it forever.”

Clinician-led at Doctors Studio, under Dr. Lisbeth Roy, DO (Founder & CEO)

Investigational, evidence-emerging (not FDA-approved for HSV)

Personalized via lab analysis

Co-managed with your existing providers (we don’t replace standard care)

Prefer to talk? Call 561-444-7751

What You Need To Know

Doctor consulting patient about herpes treatment options

You’re not alone—HSV is common and manageable

Herpes simplex virus (HSV) is a chronic, lifelong infection, and many people carry it without obvious symptoms. Transmission can occur even when someone feels fine due to intermittent shedding.

Why outbreaks keep coming back

HSV can reactivate over time. Recurrences and asymptomatic shedding are generally more frequent with HSV-2 than HSV-1.

If your outbreaks are frequent, disruptive, or emotionally exhausting, you deserve a plan that’s more precise than guesswork.

Our Treatment & How It Works

A patient-specific oligonucleotide infusion (short DNA/RNA segments) designed based on lab analysis, with the goal of interfering with replication of the targeted organism—here, HSV.

This is not a cure, and outcomes vary. But it’s a compelling precision-based option for patients who want to explore investigational strategies beyond routine antivirals.

Confirm HSV

We confirm HSV type and status using PCR/NAAT when lesions are present, or type-specific serology when they aren’t. (If you have recent results, bring them.)

Create your oligonucleotide infusion

After eligibility review and lab confirmation, we collect what’s needed to design your patient-specific infusion.

Infusion + follow-up

Q-REStrain is administered intravenously in-clinic. Follow-up is typically tracked over 4–6+ months to observe changes in symptoms/outbreak patterns.

What to Expect (Your Timeline)

Visit 1 - Eligibility Consult

Review symptoms/outbreak history

Review prior testing and current medications

Decide if you’re a candidate and outline next steps

Visit 2 - Labs & Infusion Scheduling

After eligibility + lab confirmation + blood draw, it typically takes 4–6 weeks for your personalized infusion to arrive at the clinic.

Visit 3 - Infusion Day

Your appointment is typically about 90 minutes.

We schedule check-ins to track response and help guide next best steps.

Is it right for me?

Happy couple on beach

Q-REStrain may be a fit if you:

  • Have recurrent outbreaks despite standard care

  • Want a precision approach and are comfortable with investigational options (not FDA-approved for HSV)

  • Prefer coordinated care (we collaborate with your existing clinicians)

We’ll also discuss safety considerations and your broader health context. CDC notes HSV-2 increases HIV acquisition risk, so HIV testing is often recommended as part of comprehensive sexual health care.

How this fits with standard HSV care:

CDC notes that systemic antivirals can partially control signs/symptoms and that FDA-approved antivirals (acyclovir, valacyclovir, famciclovir) provide clinical benefit. CDC also notes suppressive therapy can reduce recurrences 70–80% for those with frequent recurrences, but antivirals do not eradicate latent virus.

Our approach:

  • We do not tell patients to stop antivirals without clinician guidance.

  • We position our care as an investigational adjunct, with informed consent and realistic expectations.

*Not FDA-approved for HSV; evidence is preliminary. We provide detailed, informed consent and coordinate with your primary provider(s).

Clinician Oversight You Can Trust

This program is offered under the leadership of Dr. Lisbeth Roy, DO, Founder & CEO of Doctors Studio. Dr. Roy is described by Doctors Studio as a functional and regenerative medicine expert who emphasizes cutting-edge diagnostics and evidence-based, personalized care.

FAQ

Is this a cure?

Q-REstrain is designed to target viral replication at the genetic level, to reduce outbreak frequency and severity. However, this is not a cure, and outcomes vary between individuals. We work with you to set realistic expectations based on current evidence.

How soon can I receive it?

After eligibility, lab confirmation, and Q-REstrain blood draw, it takes 4-6 weeks to receive the personalized oligonucleotide therapy solution in the clinic.

Do I stop antivirals?

Only with clinician guidance; we co-manage care per CDC best practices.

Note: This investigational treatment uses patient-specific nucleic acid (targeted microRNA) therapy designed to bind defined viral gene sequences and interfere with HSV replication.

Check Eligibility. Contact Us Today!

Answer a few questions so we can confirm next best steps and help you book quickly.